Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study
Titel:
Blood serum amyloid A as potential biomarker of pembrolizumab efficacy for patients affected by advanced non-small cell lung cancer overexpressing PD-L1: results of the exploratory “FoRECATT” study
Auteur:
Di Noia, Vincenzo D’Argento, Ettore Pilotto, Sara Vita, Emanuele Ferrara, Miriam Grazia Damiano, Paola Ribelli, Marta Cannella, Antonella Virtuoso, Antonella Fattorossi, Andrea Ceresoli, Giovanni Luca Milella, Michele Beretta, Giordano Domenico Tortora, Giampaolo Bria, Emilio